OPIANT PHARMACEUTICALS, INC.

15.25 -0.14 (-0.91%) Sell

Prayers for OPNT investors as it delivered massive losses

13 min read

OPIANT PHARMACEUTICALS, INC. significantly underperformed today. It delivered -0.91% to close at 15.25. It's recent 5 day performance has been -3.81%, +0.63%, -0.38%, +0.19% and -0.44%.

OPNT is currently in a bearish trend. The previous short signal in OPNT has not been profitable for investors in general. If you are short on OPNT at current levels please make sure that your allocation is limited and that your portfolio is well diversified.

Trend

OPNT has been underperforming the SP500 index in recent time. It showed significant outperformance (compared to the SP500 index) from 29 Jun, 2017 to 7 Sep, 2017. Over the last 2 years 11 months and 10 days, OPNT outperformed the SP500 index on 46% days. Which indicates that on days OPNT outperforms the SP500 index, it's performance is marginally better than on the days it underperforms the SP500 index.

During the last three months OPNT was mostly loss making and delivered on average -0.52% per day. It's best return during this period (of +8.49%) was on Friday, 30 Nov, 2018. While it's worst loss in the same period (of -18.62%) was on Tuesday, 25 Sep, 2018. The longest stort-term trend during this period was 9 losing days, which started on 8 Nov, 2018 and ended on 20 Nov, 2018. This bearish trend lost -16.41% of investor capital.

The last 12 months saw OPNT's investors making profits in 5 months and incurring losses in 7 months. OPNT was less consistent in delivering monthly returs than SP500 index. OPNT significantly outperformed SP500 index in Aug 2018, when it returned +53.25% compared to +4.75% returned by SP500 index during it's best month in the last one year - Jan 2018. OPNT had a shorter streak of profitable months than SP500 index. It only went up in 2 straight months during the last year. It is interesting to note that both OPNT and SP500 index significantly outperform during months when quarterly/annual results are announced.

"Being in control of your finances is a great stress reliever.

OPNT is currently seeing overall fall in volatility. In comparison, the SP500 index is seeing increase in volatility. During the last three months, there was a significant fall in OPNT's volatility from 18 Sep, 2018 to 1 Oct, 2018. While there was a significant surge in the SP500 index's volatility from 25 Sep, 2018 to 29 Oct, 2018.

Advanced/professional short-term investors should note that OPNT has negative skewness in it's return distribution. This indicates that investors may need to stay invested through long periods of drawdown before expecting a recovery.

SP500 index has more chance of extreme outcomes than OPNT. Therefore, SP500 must receive a lower allocation than OPNT in your portfolio. SP500 index usually has shorter drawdown period than OPNT.

Based on your interest in OPNT you may find it interesting to know that TNDM has shown remarkable performance this year and deserves to be on every investors' watchlist.

Want to improve your Portfolio's performance?

Spotalpha's Portfolio optimizer is all you need to improve your returns and reduce your risk.
Optimize Portfolio NOW
Following
Symbol Price {{retType}} | Tr.
{{detail.symbol}} {{detail.close}} {{detail.priceChange}}  {{detail.pctChange}}%  {{detail.name}} {{detail.trend}} 
 
If you liked what you read here ...

... we have a small favour to ask. Help us bring the power of algorithmic trading strategies to individual investors.

All content in this article was automatically generated by algorithms. This ensures that there are no human biases in the analysis provided. This approach to investing is not new and has been around for more than three decades. Yet, it has been available to only the most affluent or elite investors leaving individual investors to trade on emotions (such as fear and greed), intuition and poor analysis from third-parties. We want to change this.

We want to empower investors with all the tools and analysis required by them to make a rational investment decision.

If you found Spotalpha useful, consider making a contribution. For as little as $5 you can support our efforts and it takes less than a minute. Thank you. Contribute
Share with friends   WhatsApp   Facebook   Twitter